Neural regulation of lysozyme secretion from tracheal submucosal glands of ferrets in vivo.
To investigate how central and peripheral nerves affect lysozyme secretion from tracheal submucosal glands in ferrets we injected substance P (20 nmol/kg in 200 microliters) intracisternally or intravenously into anesthetized artificially ventilated ferrets. We collected 3-ml samples from a perfused (3 ml/5 min) segment of trachea in situ during 15 min before and 45 min after injection of substance P. Content of lysozyme, a specific marker of tracheal submucosal gland serous cell secretion in ferrets, was measured spectrophotometrically in each sample. Intracisternal substance P increased peak lysozyme output threefold compared with baseline. This increase was abolished completely by cutting both superior laryngeal nerves (SLN) and was partially inhibited by atropine, phentolamine, or propranolol. Intravenous substance P increased peak lysozyme output 10-fold compared with baseline. This increase was partly abolished by cutting both SLN. We concluded that intracisternal substance P stimulated the central nervous system (CNS) and activated cholinergic, adrenergic, and nonadrenergic noncholinergic secretomotor nerves to tracheal glands and that intravenous substance P increased lysozyme secretion both by acting directly on tracheal glands and indirectly on the CNS to activate secretomotor nerves.
Davis
B
B
Cardiovascular Research Institute, University of California, San Francisco 94143-0130.
Tseng
H C
HC
D000818:Animals; D002946:Cisterna Magna; D005088:Exocrine Glands / Q000187:drug effects / Q000201:enzymology; D005289:Ferrets; D007267:Injections; D007275:Injections, Intravenous; D007823:Laryngeal Nerves / Q000187:drug effects / Q000502:physiology; D008297:Male; D009092:Mucous Membrane / Q000187:drug effects / Q000201:enzymology; D009113:Muramidase / Q000378:metabolism*; D009420:Nervous System / Q000187:drug effects; D009424:Nervous System Physiological Phenomena; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D009475:Neurons, Afferent / Q000187:drug effects / Q000502:physiology; D010477:Perfusion; D013373:Substance P / Q000008:administration & dosage / Q000494:pharmacology; D013618:Tachyphylaxis / Q000502:physiology; D014132:Trachea / Q000187:drug effects / Q000201:enzymology*
D013373:Substance P; D009113:Muramidase